Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)

Michele Wilson; Yoav Golan; Dianne Nguyen; Morteza Yazdani; Alpesh N. Amin

doi:10.1007/s40121-025-01266-4

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)

Michele Wilson
, Yoav Golan
, Dianne Nguyen
, Morteza Yazdani
, Alpesh N. Amin

Research output: Contribution to journal › Comment/debate

Abstract

The sentence beginning “VOS efficacy was replicated in the ECOSPOR-IV trial, a phase 4 extension arm of the VOS phase 3 trial, ….” in the Discussion section of this article, should have read “VOS efficacy was consistent in the ECOSPOR-IV trial, a phase 3 single-arm study, ….” The original article has been corrected.

Original language	English
Pages (from-to)	387
Number of pages	1
Journal	Infectious Diseases and Therapy
Volume	15
Issue number	1
DOIs	https://doi.org/10.1007/s40121-025-01266-4
State	Published - 1 Jan 2026
Externally published	Yes

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1007/s40121-025-01266-4

Fingerprint

Dive into the research topics of 'Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)'. Together they form a unique fingerprint.

Cite this

Wilson, M., Golan, Y., Nguyen, D., Yazdani, M., & Amin, A. N. (2026). Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4). Infectious Diseases and Therapy, 15(1), 387. https://doi.org/10.1007/s40121-025-01266-4

Wilson, Michele ; Golan, Yoav ; Nguyen, Dianne et al. / Correction : Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4). In: Infectious Diseases and Therapy. 2026 ; Vol. 15, No. 1. pp. 387.

@article{ab141a04da6f43c7acea1bfb274a820b,

title = "Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)",

abstract = "The sentence beginning {\textquotedblleft}VOS efficacy was replicated in the ECOSPOR-IV trial, a phase 4 extension arm of the VOS phase 3 trial, ….{\textquotedblright} in the Discussion section of this article, should have read {\textquotedblleft}VOS efficacy was consistent in the ECOSPOR-IV trial, a phase 3 single-arm study, ….{\textquotedblright} The original article has been corrected.",

author = "Michele Wilson and Yoav Golan and Dianne Nguyen and Morteza Yazdani and Amin, \{Alpesh N.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2026",

month = jan,

day = "1",

doi = "10.1007/s40121-025-01266-4",

language = "English",

volume = "15",

pages = "387",

journal = "Infectious Diseases and Therapy",

issn = "2193-8229",

publisher = "Adis",

number = "1",

}

Wilson, M, Golan, Y, Nguyen, D, Yazdani, M & Amin, AN 2026, 'Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)', Infectious Diseases and Therapy, vol. 15, no. 1, pp. 387. https://doi.org/10.1007/s40121-025-01266-4

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4). / Wilson, Michele; Golan, Yoav; Nguyen, Dianne et al.
In: Infectious Diseases and Therapy, Vol. 15, No. 1, 01.01.2026, p. 387.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)

AU - Wilson, Michele

AU - Golan, Yoav

AU - Nguyen, Dianne

AU - Yazdani, Morteza

AU - Amin, Alpesh N.

PY - 2026/1/1

Y1 - 2026/1/1

N2 - The sentence beginning “VOS efficacy was replicated in the ECOSPOR-IV trial, a phase 4 extension arm of the VOS phase 3 trial, ….” in the Discussion section of this article, should have read “VOS efficacy was consistent in the ECOSPOR-IV trial, a phase 3 single-arm study, ….” The original article has been corrected.

AB - The sentence beginning “VOS efficacy was replicated in the ECOSPOR-IV trial, a phase 4 extension arm of the VOS phase 3 trial, ….” in the Discussion section of this article, should have read “VOS efficacy was consistent in the ECOSPOR-IV trial, a phase 3 single-arm study, ….” The original article has been corrected.

UR - https://www.scopus.com/pages/publications/105022828184

U2 - 10.1007/s40121-025-01266-4

DO - 10.1007/s40121-025-01266-4

M3 - Comment/debate

C2 - 41264212

AN - SCOPUS:105022828184

SN - 2193-8229

VL - 15

SP - 387

JO - Infectious Diseases and Therapy

JF - Infectious Diseases and Therapy

IS - 1

ER -

Wilson M, Golan Y, Nguyen D, Yazdani M, Amin AN. Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4). Infectious Diseases and Therapy. 2026 Jan 1;15(1):387. doi: 10.1007/s40121-025-01266-4

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States (Infectious Diseases and Therapy, (2025), 14, 8, (1799-1813), 10.1007/s40121-025-01169-4)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this